COX-2-specific inhibitor or proton pump inhibitor plus traditional NSAID: is either approach sufficient for patients at highest risk of NSAID-induced ulcers?
- PMID: 15481002
- DOI: 10.1053/j.gastro.2004.08.029
COX-2-specific inhibitor or proton pump inhibitor plus traditional NSAID: is either approach sufficient for patients at highest risk of NSAID-induced ulcers?
Comment on
-
Celecoxib versus diclofenac plus omeprazole in high-risk arthritis patients: results of a randomized double-blind trial.Gastroenterology. 2004 Oct;127(4):1038-43. doi: 10.1053/j.gastro.2004.07.010. Gastroenterology. 2004. PMID: 15480981 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
